Endocrinology

Top Story

Several medications safe for comanagement of type 2 diabetes, osteoporosis

June 23, 2017

A recent comprehensive review published in The Journal of Clinical Endocrinology & Metabolism identifies metformin, sulfonylureas, DPP-IV inhibitors and GLP-1 receptor agonists as preferred therapies for type 2 diabetes in adults who also have osteoporosis.

Stavroula A. Paschou, MD, PhD, of the National and Kapodistrian University of Athens, Greece, and colleagues systematically reviewed past human studies and guidelines to develop recommendations for choosing medications to use when a patient has diabetes and osteoporosis.

In the Journals Plus

Maintained weight loss for 1 year increases insulin sensitivity in women

June 23, 2017
Women with overweight or obesity who maintained at least 15% reduction in body weight for 12 months were more likely to have improved insulin sensitivity when compared…
In the Journals Plus

Childhood fractures not predictive of BMD, bone strength in young men

June 23, 2017
The occurrence of fractures in boys did not predict bone fragility of men in early adulthood, study data from Switzerland and the Netherlands showed.
Meeting News

Strategies to encourage more patients to undergo eye tests

June 23, 2017
PHILADELPHIA — Education, along with a screening reminder card, may encourage more patients to get diabetic retinopathy eye screening exams, according to a…
In the Journals Plus

Sugary drink consumption associated with type 2 diabetes risk in women

June 23, 2017
Thai woman who reported consuming at least one sugar-sweetened beverage per day were twice as likely to develop type 2 diabetes over 8 years vs. those who reported…
More News Headlines »
CME

Improving Bone Strength and Reducing Fracture Risk in Osteoporosis

This activity is supported by an educational grant from Merck & Co., Inc.

Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to reduced…
More »
Video
Meeting News

VIDEO: Screening BMD crucial to diagnose fracture risk

May 3, 2017
More »
Featured
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

CME CNE CPE CE

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement